Fast-forward to May 22, 2022. I was in my GP's office, confirming what Google had told me the night before, when I found my nipple had collapsed inwards. I had breast cancer. Kristi with her mum Vicki ...
Perjeta (pertuzumab) is the first FDA-approved drug for the neoadjuvant treatment of breast cancer. Perjeta was approved in 2012 for the treatment of patients with advanced or metastatic HER2 ...
Roche subsidiary, Genentech, has announced that the US FDA has accepted its supplemental Biologics License Application (sBLA) for the use of a Perjeta (pertuzumab) regimen before surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback